We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.
Epoxide hydrolase
From Proteopedia
(Difference between revisions)
| Line 6: | Line 6: | ||
== Disease == | == Disease == | ||
| - | Inhibitors of ''Mycobacterium tuberculosis'' EH such as urea derivatives, are used as anti-tuberculosis drugs. The valpromide inhibitor of EH is used as anti-epileptic drug. | + | Inhibitors of ''Mycobacterium tuberculosis'' EH such as urea derivatives, are used as anti-tuberculosis drugs. The valpromide inhibitor of EH is used as anti-epileptic drug. Soluble EH plays a role in several diseases including cardiovascular ones and is a drug target for their therapy <ref>PMID:19794443</ref>. |
== Relevance == | == Relevance == | ||
Revision as of 21:10, 19 January 2016
| |||||||||||
3D Structures of epoxide hydrolase
Updated on 19-January-2016
References
- ↑ Imig JD, Hammock BD. Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases. Nat Rev Drug Discov. 2009 Oct;8(10):794-805. doi: 10.1038/nrd2875. PMID:19794443 doi:http://dx.doi.org/10.1038/nrd2875
